Fluorescently labeled antibodies provide the CD45-specific signal, while light-scattering measurements add information about each particle’s physical characteristics. Flow cytometry combines these signals so investigators can identify leukocyte populations and examine their fluorescence and scattering patterns together. This multi-signal approach supports more informative immune profiling than either signal alone.
CD45 detection supplies a marker for most nucleated hematopoietic cells, whereas nonhematopoietic material generally lacks that leukocyte-associated signal. In a mixed sample, comparing antibody fluorescence with light-scattering behavior helps separate white blood cells from other material. This distinction improves interpretation of cellular composition and supports assessment of sample quality.
Changes in the abundance or phenotype of CD45-detected leukocyte populations can provide evidence of altered immune composition. During infection or another immune response, investigators can use these shifts to characterize how white-cell populations change rather than relying only on total sample appearance. The resulting profile supports studies of host responses to pathogens.
A basic workflow begins with a sample containing cells, exposure to fluorescently labeled antibodies that bind CD45, and flow-cytometric measurement of fluorescence and light scattering. Investigators then use the combined signals to identify and characterize leukocyte populations. The procedure therefore links molecular recognition by the antibody with population-level cellular analysis.
In leukemia classification, CD45 testing contributes an immunological dimension to cell characterization. Because the assay detects a leukocyte-associated membrane protein and can be combined with light-scattering and fluorescence information, it helps investigators evaluate cellular populations within a sample. Its value lies in supporting classification alongside broader flow-cytometric characterization.
For sample quality assessment, the assay can indicate whether the analyzed material contains the expected leukocyte signal and how cellular populations are represented. In host-pathogen research, the same measurements allow investigators to examine changes in leukocyte abundance or phenotype during immune responses. Thus, one assay connects sample evaluation with infection-focused immune profiling.